Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy
Seminars in Liver Disease · 01.08.2023 · 43 (03) · 323-335
DOI: 10.1055/a-2153-8927 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Liver Disease, erschienen am 01.08.2023. Verfasst von Dominick J Hellen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta,…. Hauptthemen laut MEDLINE: Biliary Atresia, Cholestasis, Liver Transplantation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Biliary atresia (BA) is the most prevalent serious liver disease of infancy and childhood, and the principal indication for liver transplantation in pediatrics. BA is best considered as an idiopathic panbiliary cholangiopathy characterized by obstruction of bile flow and consequent cholestasis presenting during fetal and perinatal periods. While several etiologies have been proposed, each has significant drawbacks that have limited understanding of disease progression and the development of effective treatments. Recently, modern genetic analyses have uncovered gene variants contributing to BA, thereby shifting the paradigm for explaining the BA phenotype from an acquired etiology (e.g., virus, toxin) to one that results from genetically altered cholangiocyte development and function. Herein we review recently reported genetic contributions to BA, highlighting the enhanced representation of variants in biological pathways involving ciliary function, cytoskeletal structure, and inflammation. Finally, we blend these findings as a new framework for understanding the resultant BA phenotype as a developmental cholangiopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia.
ORCID-Profile: Dominick J Hellen, Saul J Karpen
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIH
- Mason Trust
Zitieren
APA
Hellen, D. J., & Karpen, S. J. (2023). Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy. Seminars in Liver Disease, 43(03), 323-335. https://doi.org/10.1055/a-2153-8927
Vancouver
Hellen DJ, Karpen SJ. Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy. Seminars in Liver Disease. 2023;43(03):323-335. doi:10.1055/a-2153-8927
BibTeX
@article{Hellen2023,
author = {Hellen, Dominick J and Karpen, Saul J},
title = {Genetic Contributions to Biliary Atresia: A Developmental Cholangiopathy},
journal = {Seminars in Liver Disease},
year = {2023},
volume = {43},
number = {03},
pages = {323--335},
doi = {10.1055/a-2153-8927}
}
EUVIMED